Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 01-05-2011, 03:42 PM #11
Grammie 2 3 Grammie 2 3 is offline
Member
 
Join Date: Aug 2007
Location: Colorado
Posts: 374
15 yr Member
Grammie 2 3 Grammie 2 3 is offline
Member
 
Join Date: Aug 2007
Location: Colorado
Posts: 374
15 yr Member
Default

I was looking at the chefarzfrau site. I've had a question about a couple of the pml cases statistics and decided to throw it out to see if anyone has an answer. There are 2 cases in the U.S. both July 2010, one had 57 infusions the other 59. Tysabri was put back on the market July 2006, getting an infusion every 4 weeks would put the most infusions at 52-53 at 7/2010. If they had been in the trial they would've had many more infusions. So... I am confused

Thanks
Linda
Grammie 2 3 is offline  
"Thanks for this!" says:
Riverwild (01-06-2011), shayna (01-12-2011)
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
LDN Information & Check-in 2 SallyC Multiple Sclerosis 827 07-07-2017 09:46 PM
Tysabri Information & Check In Curious Multiple Sclerosis 988 04-16-2009 05:09 PM
LDN Information & Check In SallyC Multiple Sclerosis 844 01-15-2009 11:40 AM
Part 2...Medicare Part D/Prescription Coverage Stitcher Parkinson's Disease 1 12-17-2006 12:50 AM


All times are GMT -5. The time now is 03:23 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.